4.5 Article

D-(+)-iso-methanocarbathymidine:: A high-affinity substrate for herpes simplex virus 1 thymidine kinase

Journal

CHEMMEDCHEM
Volume 3, Issue 7, Pages 1129-1134

Publisher

WILEY-BLACKWELL
DOI: 10.1002/cmdc.200800027

Keywords

antiviral agents; asymmetric synthesis; carbocyclic nucleosides; enantiomers; HSV thymidine kinase

Funding

  1. Intramural NIH HHS [Z01 BC006174-22] Funding Source: Medline

Ask authors/readers for more resources

The stereoselective syntheses of the (+)-D and (-)-L enantiomers of iso-methanocarbathymidine (iso-MCT) was achieved through two independent linear approaches that converged on two antipodal enantiomers, common to a key precursor used in the synthesis of racemic iso-MCT In the study reported herein we identified (+)-3 [D-(+)-iso-MCT] as the active enantiomer that was exclusively recognized by the herpes simplex virus 1 thymidine kinase (HSV1-tk), as was predicted by molecular modeling. For this purpose, a human osteosarcoma (HOS) cell line modified to contain and express HSV1-tk from herpes simplex virus 1 (HSV1) was used to determine the cytotoxicity of the compounds by an assay that measures the level of ATP in the cells. The work demonstrates that changes in the substitution pattern of rigid bicyclo[3.1.0]hexane nucleosides, which, relative to normal nucleosides, appear unconventional, can lead to the spatial optimization of pharmacophores and vastly improved substrate recognition.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Medicine, Research & Experimental

LongShengZhi capsule inhibits doxorubicin-induced heart failure by antioxidative stress

Shuai Xu, Yuanyu Wang, Maoyun Yu, Dandan Wang, Yingquan Liang, Yuanli Chen, Chenzhong Liao, Zhouling Xie, Buchang Zhao, Jihong Han, Yajun Duan, Xiaoxiao Yang

BIOMEDICINE & PHARMACOTHERAPY (2020)

Article Medicine, Research & Experimental

NaoXinTong Capsule ameliorates memory deficit in APP/PS1 mice by regulating inflammatory cytokines

Xuerui Wang, Zequn Yin, Peichang Cao, Shihong Zheng, Yuanli Chen, Maoyun Yu, Chenzhong Liao, Zhongyuan Zhang, Yajun Duan, Jihong Han, Shuang Zhang, Xiaoxiao Yang

Summary: Alzheimer's disease (AD) is the most common neurodegenerative disease in aging population. The traditional Chinese medicine NaoXinTong Capsule (NXT) has been shown to improve spatial memory impairment and cognitive decline in AD mice by reducing p-Tau levels and A beta accumulation in the brain. This neuroprotective effect is achieved by inhibiting inflammatory cytokines and mediators, thereby suggesting the potential application of NXT for AD treatment.

BIOMEDICINE & PHARMACOTHERAPY (2021)

Article Chemistry, Medicinal

Small-Molecule Kinase Inhibitors for the Treatment of Nononcologic Diseases

Zhouling Xie, Xiaoxiao Yang, Yajun Duan, Jihong Han, Chenzhong Liao

Summary: Kinase inhibitors have been successful in treating various diseases beyond cancer, including autoimmune diseases and inflammatory diseases. Several non-oncologic small-molecule kinase inhibitors have been approved, with more in development for different applications.

JOURNAL OF MEDICINAL CHEMISTRY (2021)

Article Chemistry, Medicinal

Dual nicotinamide phosphoribosyltransferase and epidermal growth factor receptor inhibitors for the treatment of cancer

Wanheng Zhang, Kuojun Zhang, Yiwu Yao, Yunyao Liu, Yong Ni, Chenzhong Liao, Zhengchao Tu, Yatao Qiu, Dexiang Wang, Dong Chen, Lei Qiang, Zheng Li, Sheng Jiang

Summary: The study developed the first compounds that simultaneously inhibit NAMPT and EGFR, with compound 28 showing good inhibitory effects and demonstrating anti-tumor efficacy in vitro and in vivo. This research provides promising leads for the development of novel anti-tumor agents.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2021)

Article Biochemistry & Molecular Biology

NGBR is required to ameliorate type 2 diabetes in mice by enhancing insulin sensitivity

Yi Chen, Wenquan Hu, Qi Li, Shiwei Zhao, Dan Zhao, Shuang Zhang, Zhuo Wei, Xiaoxiao Yang, Yuanli Chen, Xiaoju Li, Chenzhong Liao, Jihong Han, Qing Robert Miao, Yajun Duan

Summary: Reduced expression of NGBR in the liver is associated with obesity-related T2D in patients and mice, while overexpression of NGBR can improve insulin sensitivity and reduce beta-cell loss.

JOURNAL OF BIOLOGICAL CHEMISTRY (2021)

Article Chemistry, Medicinal

Novel 1-(prop-2-yn-1-ylamino)-2,3-dihydro-1H-indene-4-thiol derivatives as potent selective human monoamine oxidase B inhibitors: Design, SAR development, and biological evaluation

Haiyan Kong, Xianshe Meng, Rui Hou, Xiaoxiao Yang, Jihong Han, Zhouling Xie, Yajun Duan, Chenzhong Liao

Summary: This study developed 1-(prop-2-yn-1-ylamino)-2,3-dihydro-1H-indene-4-thiol derivatives as hMAO-B inhibitors, among which K8 and K24 showed promising inhibitory activities and selectivity. These compounds have potential applications for Parkinson's disease treatment.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2021)

Article Chemistry, Medicinal

Zinc enzymes in medicinal chemistry

Rui Hou, Yan He, Guangwei Yan, Shuzeng Hou, Zhouling Xie, Chenzhong Liao

Summary: In humans, over three hundred enzymes dependent on zinc have been identified, some of which are considered valuable targets for drug discovery. Many drugs targeting these zinc enzymes have been marketed for treating various diseases. This review discusses drug discovery and development based on zinc enzymes, including biological functions, pathogenic roles, inhibitors, binding modes, and challenges in developing zinc enzyme inhibitors for human disorders.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2021)

Article Agriculture, Multidisciplinary

Riboflavin Bioenriched Soymilk Alleviates Oxidative Stress Mediated Liver Injury, Intestinal Inflammation, and Gut Microbiota Modification in B2 Depletion-Repletion Mice

Yun-Yang Zhu, Kiran Thakur, Jing-Yu Feng, Jian-Guo Zhang, Fei Hu, Carlos L. Cespedes-Acuna, Chenzhong Liao, Zhao-Jun Wei

Summary: The study reveals that B2FS can effectively alleviate the detrimental effects of ariboflavinosis, including oxidative stress-mediated liver injury, chronic intestinal inflammation, and gut dysbiosis, through the activation of the Nrf2 signaling pathway in the B-2 depletion-repletion mice model.

JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2022)

Article Chemistry, Medicinal

Lessons Learned from Past Cyclin-Dependent Kinase Drug Discovery Efforts

Zhouling Xie, Shuzeng Hou, Xiaoxiao Yang, Yajun Duan, Jihong Han, Qin Wang, Chenzhong Liao

Summary: Inhibition of CDK has proven to be an effective strategy for treating various diseases, particularly cancer. However, the development of CDK inhibitors has faced difficulties and misunderstandings, such as inadequate understanding of CDK's biological functions and the overlooking of the importance of multi-CDK inhibitors. This article summarizes and discusses these issues, aiming to facilitate the discovery of more useful CDK inhibitors.

JOURNAL OF MEDICINAL CHEMISTRY (2022)

Article Chemistry, Medicinal

Targeting the S2 Subsite Enables the Structure-Based Discovery of Novel Highly Selective Factor XIa Inhibitors

Ningning Yao, Zhiping Jia, Yongbin Tian, Shuzeng Hou, Xiaoxiao Yang, Jihong Han, Yajun Duan, Chenzhong Liao, Yi Kong, Zhouling Xie

Summary: In this study, novel selective FXIa inhibitors were identified through structure-based drug design strategies, which have extra interactions with the S2 subsite of FXIa. Compound 35 displayed good inhibitory activity against FXIa and high selectivity over PKal and other serine proteases. In vivo experiments showed that 35 exhibited significant antithrombotic activity without increasing bleeding risk and toxicity in mice, suggesting it as a promising candidate for further research.

JOURNAL OF MEDICINAL CHEMISTRY (2022)

Review Chemistry, Medicinal

Discovery of Polo-like Kinase 4 Inhibitors for the Treatment of Cancer: A Mini Patent Review

Yang Shu, Yajing Liu, Shirong Bian, Zhouling Xie, Chenzhong Liao

Summary: Polo-like kinase 4 (PLK4) is a key regulator of the cell cycle that controls centrosome duplication and mitosis. It has been identified as a promising target for cancer therapy, and PLK4 inhibitors have shown potential for treating various cancers and other PLK4-associated human disorders. In addition, PLK4 may have a role in sensitizing DNA damage, thus improving the efficacy of chemotherapy. However, there is still limited understanding of PLK4, and further research is needed to identify novel mechanisms.

MINI-REVIEWS IN MEDICINAL CHEMISTRY (2023)

Article Chemistry, Multidisciplinary

Roxadustat alleviates nitroglycerin-induced migraine in mice by regulating HIF-1α/NF-κB/inflammation pathway

Dai-gang Yang, Yong-yao Gao, Ze-qun Yin, Xue-rui Wang, Xian-she Meng, Ting-feng Zou, Ya-jun Duan, Yuan-li Chen, Chen-zhong Liao, Zhou-ling Xie, Xiao-dong Fan, Lu Sun, Ji-hong Han, Xiao-xiao Yang

Summary: Sensitization of central pain and inflammatory pathways plays a critical role in migraine, and this study demonstrates that the HIF-1 alpha/NF-kappa B/inflammation pathway is involved in this process. Roxadustat, a HIF-1 alpha stabilizer, shows potential as a therapeutic option for migraine by ameliorating migraine-like behaviors and inhibiting central pain sensitization.

ACTA PHARMACOLOGICA SINICA (2023)

Article Chemistry, Multidisciplinary

Fisetin treatment alleviates kidney injury in mice with diabetes-exacerbated atherosclerosis through inhibiting CD36/fibrosis pathway

Ting-feng Zou, Zhi-gang Liu, Pei-chang Cao, Shi-hong Zheng, Wen-tong Guo, Tian-xiang Wang, Yuan-li Chen, Ya-jun Duan, Qing-shan Li, Chen-zhong Liao, Zhou-ling Xie, Ji-hong Han, Xiao-xiao Yang

Summary: The study investigated the therapeutic effects of fisetin, a natural flavonoid, on kidney injury caused by diabetic atherosclerosis. The results showed that fisetin effectively attenuated diabetes-exacerbated atherosclerosis and ameliorated atherosclerosis-enhanced diabetic kidney injury. Fisetin reduced oxidative stress, glycosylation end products, and inflammation while regulating the expression of proteins involved in extracellular matrix and renal fibrosis.

ACTA PHARMACOLOGICA SINICA (2023)

Article Chemistry, Medicinal

Factor XIa Inhibitors in Anticoagulation Therapy: Recent Advances and Perspectives

Zhouling Xie, Zhiwei Meng, Xiaoxiao Yang, Yajun Duan, Qin Wang, Chenzhong Liao

Summary: This article introduces FXIa as an effective and safe target for anticoagulant discovery, and discusses the recent progress in the design, discovery, structure-activity relationships, and development of small-molecule FXIa inhibitors. The strategies for identifying more selective and druggable inhibitors are also provided, which may lead to the development of more useful anticoagulant therapies.

JOURNAL OF MEDICINAL CHEMISTRY (2023)

Article Biochemistry & Molecular Biology

Apigenin protects mice against 3,5-diethoxycarbonyl-1,4-dihydrocollidine-induced cholestasis

Shihong Zheng, Peichang Cao, Zequn Yin, Xuerui Wang, Yuanli Chen, Maoyun Yu, Baocai Xu, Chenzhong Liao, Yajun Duan, Shuang Zhang, Jihong Han, Xiaoxiao Yang

Summary: Apigenin can improve cholestasis induced by DDC by reducing inflammation and oxidative damage, and improving bile acid metabolism, indicating its potential application for cholestasis treatment.

FOOD & FUNCTION (2021)

No Data Available